Beyond's stock outlook worsens as analyst downgrades shares, delays EBITDA milestone to 2027, and warns of increased ...
As previously reported, Needham analyst Bernie McTernan downgraded Beyond (BYON) to Hold from Buy and removed its prior $9 price target citing ...